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Abstract
Healthcare changes dramatically because of technological develop-
ments, from anesthetics and antibiotics to magnetic resonance imag-
ing scanners and radiotherapy. Future technological innovation is
going to keep transforming healthcare, yet while technologies (new
drugs and treatments, new devices, new social media support for
healthcare, etc) will drive innovation, human factors will remain one
of the stable limitations of breakthroughs. No predictions can satisfy
everybody; instead, this article explores fragments of the future to see
how to think more clearly about how to get where we want to go. 
Introduction
Pluck a nurse and surgeon out of the nineteenth century and trans-
port them into a modern 21st century hospital and it would be a thor-
oughly recognizable place, with the same hierarchies and strict cul-
tures. Patients treated as helpless, stripped of their clothes and pos-
sessions, lying in beds and almost completely ignorant of their illness.
They might be disappointed in our treatment particularly of old people,
but I don’t think it would surprise them.
If our two time-travellers were able to attend a post-mortem and lis-
ten in on a discussion of human error, very little would seem novel.
Clinicians would still be in denial, lawyers would still be hovering, and
the delay and deny culture would be no surprise. However, the changes
that would surprise the nurse and surgeon are all changes to technol-
ogy. Infusion pumps, dialysis machines, antibiotics, heart valves, MRI
scanners, even hand washing stations would be new ideas. All the hid-
den technology used in the laboratories behind the scenes, from path
labs to decontamination, would be startlingly new if it was noticed. 
Although the medical culture is similar, there have been dramatic
technological changes, and actually these changes would be hard to
explain. Does anybody even know how an infusion pump works? They
used to be clockwork (and before that, gravity fed) and now almost
everything contains a computer and has a colourful screen and lots of
buttons. Implanted defibrillators that use telephone networks and web
sites to keep cardiologists up to date with their patients are just magic;
new pharmaceuticals that change moods, change blood pressure, or
kill bacteria: all are modern magic. On reflection, given the centuries
of stability, it is amazing how much healthcare has changed in the last
150 years − and one wonders how this accelerating pace of change will
proceed in the future.
Arthur C. Clarke, the prolific futurist and science fiction writer,
famously said that any sufficiently advanced technology is indistin-
guishable from magic. Perhaps the main difference for the couple lift-
ed out of the nineteenth century is they are sure it’s magic, whereas
we have stopped thinking about it, and just take it for granted!
Time-traveling fiction starts to dig into many interesting issues we
might normally avoid thinking about. What about organ harvesting?
What about enhanced humans? What about the end of antibiotics? Will
robots take over? And so on. 
Some of what seems to us today like science fiction is going to be
routine in the future, perhaps even in our lifetimes. Yet much of
today’s human story about relationships, hopes, error, grief and denial
is going to remain entirely recognizable in the future. We will still
have authority gradients, we will still have controversy over human
error, and patients will still be made helpless so that they are easier to
treat. The reason is that technology is driven by the market: if some-
body has an idea that they can turn into a physical realization that they
can sell, they can also patent it or license it, and thereby make a return
on their investment.  This, in turn, will encourage them to find ways
of making it smaller and cheaper, and marketing it on a larger scale;
thus it is technology-driven. In contrast, human culture does not make
profit for anybody. Improving culture means admitting somebody or
some process was not good enough to start with, and who wants to do
that, especially when lawyers are watching? There is little economic
incentive to improve culture.
Atul Gawande makes a similar point about the World Health
Organization’s Surgical Safety Checklist.1 The checklist is a simple
piece of paper that helps change human behaviour − it helps check the
patient has been correctly identified, helps introduce everybody by
name (to reduce authority gradients), and so on. It’s simple and saves
lives − more effectively than many drugs. Gawande asks who will pro-
mote such an idea when nobody makes any profit from it? It’s just a bit
of paper anybody can print. If it was a technology (such as a patented
drug) that promised the same improvements in outcomes, everybody
would be buying it, and the pharmaceutical company making it would
be promoting it heavily. Patients would ask for it to be used. But a
piece of paper anybody can print is not exciting enough. Crucially, the
only person who benefits from the checklist is the patient (the clini-
cians benefit indirectly, because more successful operations mean less
litigation). The patient is probably unconscious at the very moment
they ought to be asking for it!Science fiction
Our time-travelling fiction is a small example of the power of using
science fiction to help envisage and plan our future. In contrast to the
usual tunnel vision prediction of future trends, which often highlight
glowingly positive ideas, science fiction lets us explore and communi-
cate futures we want to live in by telling rounded stories we can
engage with. More importantly, science fiction can also explore
Significance for public health
Technology drives healthcare more than any other force, and in the future it
will continue to develop in dramatic ways. While we can glimpse and debate
the details of future trends in healthcare, we need to be clear about the driv-
ers so we can align with them and actively work to ensure the best outcomes
for society as a whole.
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dystopian futures we want to avoid; George Orwell’s 1984 helped avoid
his dystopia happening (so far anyway). 
In the present paper we have not space to create further stories, but
we commend the method to both manufacturers and consumers of
technology − the hospitals, clinicians and patient groups, and especial-
ly to designers.2
When we tell good stories, we get into them, but there is not one
story about the future. Anything is possible, and we need lots of stories,
to explore good and bad and indifferent choices. Moreover, when we get
to the future, it too will have another future. There is not one future,
but many. We will never find satisfactory solutions to anything, as there
will always be new things to try and explore. This week it might be the
Cloud or improved natural language processing, but before we’ve got
that working properly, somebody will have invented something that
solves even more problems and sounds equally seductive. Yet while
technology drives changes in healthcare, the fundamental problems of
wellbeing, health and happiness, will remain. 
The easy story is that the future will be better. Technology will
advance and there will always be new and exciting solutions. Today we
have robotic keyhole surgery, and things can only get better. We have
intelligent decision aids to improve diagnosis, and they will only get
better. Some people would point to the underlying drivers: technology is
getting faster, better and smaller. Moore’s Law says the speed of inno-
vation is accelerating. The simple story is we will just enjoy the ride.
However, the more complex story exposes trade-offs. For example, new
computers are indeed much faster, but to take advantage of them we
first have had to throw away the slower computers so they can be
replaced, and then we may well discover the patient information on the
old computers won’t work on the new ones. In fact, we are in a contin-
ual struggle to keep up − it costs us a lot, and a lot of solutions that
excited us yesterday are already in landfill. The faster we go, then, the
more we can expect incompatibilities, and indeed greater spread
between those at the sharp end of developments and those without the
resources to benefit. When we honestly think about the future, we have
to broaden our spotlight from the few exciting ideas that attract our
attention to the wider issues, the broader context of change and com-
plexity, in which those innovations could be used effectively. As good
science fiction does so well, turning an exciting idea into a fully-
worked out story helps us explore the issues more realistically.
Rather than develop a single story about the future, this paper now
turns to presenting principles, themes and scenarios that a good writer
might integrate to create a coherent picture.Key points about futures for healthcare
Patients are the reason for healthcare and they should be at the cen-
tre of it. This article, however, is about possible technological trends
and drivers in healthcare; it should therefore be read in conjunction
with patient-cantered perspectives like the Royal College of Physician’s
Future Hospital: Caring For Medical Patients report.3
Technology does not have an agenda of helping healthcare, however
much we might like to focus on benefits. It develops because of minia-
turization, lowering costs of production, and so on, not because it
makes people well, but rather because it can find ways of making
money and reinvesting it. Koppel and Gordon’s edited book First Do Less
Harm is recommended as an overview of issues.4
The pace of change is accelerating: our time travellers from a hun-
dred years ago were surprised at a few things, but had they travelled
back in time, with a few minor bumps like William Harvey discovering
blood circulation, very little changes all the way back to Hippocrates.
Human nature does not change, at least not on these technological
timescales. The authority structures in healthcare, the division of
labour, the pretence that clinicians know everything, and other human
factors are slow to change. Despite our knowledge of germ theory and
antisepsis, we are still resistant to washing our hands.
There are many futures to plan for. As soon as we get to our future,
there will be another − and we will increasingly be seeing partially-
completed solutions superseded by even better ideas. Today we might
be thinking we just need to computerize all patient records, but before
we’ve finished doing that some fancy new technology will change what
we want to do or how we should do it. For the foreseeable future, we will
have to live with fragmented and partially working technologies.
We need to take the future seriously as, literally, it is all we have, and
certainly all our children will have − and we can be certain that as we
get older, we are going to end up with all the problems of old age.
Surely, we want healthcare to improve in the future? We should put
effort into future planning, not once, but continuously. 
In the rest of this article, we will make repeated comparisons
between technological factors and human factors. Often these drivers
are not aligned (one of the key messages of this article), and technol-
ogy is therefore unlikely to develop in ways that are optimal for health-
care on its own accord. Our concepts of ourselves, from conception to
death, as individuals, families and as communities, are inextricably
linked to technological possibilities. We ought to have a Future
Healthcare Institute, which will be kept continually busy prioritizing
and reprioritizing principles to guide and align healthcare and techno-
logical developments together. One imagines such an institute giving
guidance legal and regulatory guidance, for example as has already
happened in ad hoc ways in some countries addressing advances such
as fertilization technologies. 
Technical factors
Healthcare is just a market for technology where consumers such as
hospitals are happy to pay enormous amounts of money, particularly for
prestige equipment, such as PET and MRI scanners and linear acceler-
ators.Accelerated cost savings
Technology automates and extends things that previously had to be
done by people. Before infusion pumps, nurses had to give injections
every so often; the infusion pump technology automated that. Now the
nurse’s time is freed up for other activities, and if the manufacturer
has used technology in the production of the infusion pump − as they
surely will have − they can reduce the cost of production for exactly the
same reasons. Some plastic moulding process will make millions of
infusion pumps as easily as it makes one; once one infusion pump has
been programmed in software, it costs essentially nothing to program
them all. This virtuous circle of using technology to make technology
ensures prices drop, market share increases, and profit margins
increase, which in turn allows the manufacturer to invest in more cun-
ning production and distribution technologies.
However, what is important to notice is that these benefits do not
accrue to custom or rare problems that cannot be mass-produced. This
means that a technology like an MRI scanner that can scan anyone
equally well is going to be much more popular than a technology that
has to be customized to a particular patient’s conditions.Personal healthcare
Already, the assumptions of mass production are changing. For
example, today’s 3D printers are capable of making objects of any
shape; they are slightly less efficient than standard mass production,
but the costs of custom objects of certain sorts has been lowered signif-
icantly. It is now possible to custom make titanium implants the right
shape and size to fit. Going further, it is widely envisaged that custom
drugs will be manufactured, customized to the patient’s disease and
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genetic makeup. While this seems to be enormously beneficial to
patients, there are dangers. For example, a customized drug may be
very effective, but its side effects will be unique to the patient too, and
therefore harder to diagnose and manage.
Personal healthcare has an interesting technological imperative. If
we can personalize healthcare, we get population-sized markets:
instead of selling to clinicians, manufacturers can sell to individuals −
a market 1000s of times larger.Big data
Patients generate huge amounts of information − patient records −
from X-rays to blood test results. Replacing paper with computerized
summaries makes patient care easier and more efficient. In the future
the quantity of information will increase dramatically because of
genomics (and the huge genomics of our symbiotic bacteria) and per-
sonalized medicine, and as more patient data is collected, more
insights will become available. 
If computers collect data on patient illness, treatments and out-
comes, one automatically obtains valuable information on the effective-
ness of those treatments, or relations between side effects and patient
characteristics across whole populations. Huge amounts of data will be
collected, hence the name big data. Once the infrastructures have been
set up, the incremental cost of adding one new patient will be essen-
tially nothing, and this economy of scale will drive further technical
developments. Epidemiologists will benefit enormously, but the bene-
fits to individuals are less obvious, except in the long run from big
data’s contribution to the progress of medical science more generally.Social media, patient power, mobile health and education
Stopping people going to hospital in the first place and empowering
people to care for themselves and their families is something comput-
ers are already doing well. But as patients are empowered, is their new-
found knowledge helpful or unrealistically raising their expectations?
Today, the internet is problematic, as there is no consistent way anyone
can distinguish snake oil from sense, how patients can distinguish rea-
sonable treatment from misguided hope − there will always be a lot of
solutions hunting for the patient’s money. Technical solutions to this
problem include providing accredited high-quality information; cultur-
al solutions include improving education. When somebody has a knee
injury at 40 this should not be the first time they encounter the bewil-
dering amount of variable information and social media on the inter-
net! Their management of their condition − whatever it is − would be
much improved if they had been exposed to sensible strategies since
preschool.Dramatic, transformational integration of technologies
There is not space here to fully explore the vast range of likely and
significant technological breakthroughs. Consider nanohealth, brain
implants, artificial organs, networked sensors, genomics, exoskeletons
… just a few of the potentially transformative developments already
under way. Some of these technologies are going to transform our
whole approach to illness and health − in the same way that the nine-
teenth century development of anaesthetics changed society’s moral
approach to pain. Pain and suffering used to be inevitable; now we like
to think we have a right to painless procedures − and in turn this has
influenced everything, from our treatment of patients to our treatment
of animals (why should animals suffer? is a very modern question).
New technologies, like nanohealth, are going to have ethical implica-
tions that will be hard to anticipate. Sometimes ethical issues will be
hard to negotiate because they will be apparent only after somebody
has got things working and already has a business-driven perspective.
Security, privacy and monitoring
In a world beset with major security concerns (like terrorism) it is
inevitable that all technologies, even in those healthcare, will be
aligned with national priorities. For example, taking patients’ finger-
prints and other biomedical identifiers will become easier (perhaps
driven by consumer finance, such as credit card security); and, as it
becomes easier, gathering data for state security will happen as a side-
effect of routine clinical practice. The state will be able to identify ille-
gal immigrants and outlaws and others; the current notion of patient
confidentiality will be eroded in a way that will be impossible for clini-
cians to control. 
Today we may think this would be objectionable, but it is salutary to
remember that we happily divulge all sorts of personal information dur-
ing our use of mobile phones, credit cards, as well as during our use of
the internet. We unthinkingly sacrifice our privacy because of the huge
convenience of buying stuff on the internet. It seems to make losing
our identities a trivial price to pay. When considering future healthcare
trends we can expect similar trade-offs; it will be easy to slide into lev-
els of surveillance we do not now like, falling for it because of the
healthcare benefits we want. Surveillance is not the only downside of
course − paying data rights owners; paying software licenses; signing
off responsibilities for insurance liabilities − all happen, and are often
signed off without sufficient thought.
It is increasingly trivial to collect data about patients and the quality
of patient care. This information can be aggregated and help discover
variation in treatment and outcomes, and hence help improve quality −
which is good. On the other hand, data inevitably distances the manag-
er from the patient as an individual: perhaps the fundamental notions
of patient care will lose out to organizational or state concerns, because
cost management and security, not care, becomes to be the point of the
information.Health 2.0
There are many areas where the scale and unit profits of the health-
care market will drive technical developments. Collectively, this tech-
nology-driven progress in healthcare is sometimes called Health 2.0, to
distinguish it from what we are doing now − Health 1.0. While Health
2.0 is exciting, it is sobering to realize that perhaps it is just the start
of an upgrade path: Health 2.0 will have problems we solve with Health
3.1, and in turn that will develop into Health 4 or whatever. While it
seems obvious technology will continually advance, it is going to be
harder to ensure that each iteration of technology satisfactorily
achieves what it claims to achieve, without having to be fixed up and
upgraded soon after. 
Unfortunately, few manufacturers stay in business selling us perfect
solutions; they stay in business by selling us something to keep us con-
suming: a service, something to rent, a disposable product, a product
that wears out, or a product that goes obsolete. Certainly Health 2.0 will
lead inexorably to more developments, whatever they will be. The dan-
ger is that it will make us eager to upgrade before we have even real-
ized the promised benefits of Health 2.0. Somehow, we need to work
with manufacturers to align their interests of staying in business with
our interests of having a predictable and stable life. We might do that
by distinguishing infrastructure, which is provided about once, with
consumables that are provided regularly. This is the economic model of
infusion pumps: you buy an infusion pump once, but the giving sets are
replaced after each infusion. Over time, the manufacturer makes more
profit on the easily reproduced plastic tubing than the complex pump,
and everyone is happy.
In some areas, the consumables will be information itself. This costs
nothing to reproduce, but people own it and want to make a return on
their investment. Thus patient data will be owned so that its owners −
rarely the patients! − can make money from it. Information is stored in
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computers in data formats, and often these are proprietary: the format
of a patient data system belongs to the manufacturer. This leads to the
danger that the patient data is inaccessible except on the terms the
manufacturer imposes. It may be costly to convert it into other formats,
say to upgrade to a different manufacturer’s systems. Worse, if a man-
ufacturer goes bust, some data may be lost. This is a very real problem,
as our inability to use data on paper tape, cards, cassette tapes, mag-
netic tape, VHS tapes − none of them very old technologies − and so
forth, testifies. A desirable technological trend, then, in fact a trend
that bucks the trend to date, has to be the assurance that data remains
accessible and usable over long periods of time − at least a 100 years,
which is way longer than any electronic technology!Hacking and open health
Healthcare sensors can be readily bought off the internet, and it is
easy for technically-minded people today to build sophisticated equip-
ment (to hack) to collect and analyse any personal or clinical data using
their own computers. Credit-card sized computers like Arduinos and a
few biomedical sensors cost about the same as a drug prescription! 
Some individuals are already obsessed with collecting as much
health-related data as they possibly can about themselves − it is not
just people will illnesses, but people who want to lead healthier
lifestyles or be better athletes. If these people upload their data and
contribute to aggregated data, they are contributing to citizen health −
just like open science,5 except tackling healthcare problems. At its sim-
plest, they would be contributing to epidemiological studies; at its best,
they would be helping build databases and web systems that other peo-
ple can find their medical conditions in, and hence find support com-
munities. Many patients end up with more time on their hands than
they expected, and this is how some choose to use their time: solving
their own problems and helping others. 
Hacking is not restricted to patients: a doctor using a laryngoscope
has the choice of paying commercial prices for a video recorder (e.g., to
record images to send to an ENT specialist), or more conveniently
recording the video on their iPhone − about a 1,000 times cheaper. 
The point is, technology is empowering people to do what they want
to do, and in the future patients are going to take some of the initiative
away from professional healthcare, particularly for diagnosis, chronic
illnesses, and lifestyle advice.Technology is diverse and surprising
These are some of some powerful technological drivers, and it is
hard to draw a line under the discussion. We have not discussed many
technologies that are both critical and exciting such as nanohealth,
personalized healthcare, mobile health, telehealth and so on − the
beginnings of all of these are already available and in use in first
adopter places. What the brief discussion illustrates is the diversity, the
rapid pervasiveness, and the complex trade-offs of future technologies.Bridging future gaps
The science fiction author William Gibson says the future has
already happened − we just don’t know where. All the ideas we discuss
in this article about the future have happened.
From considering technological drivers, we now turn to human
futures. We believe these will be more stable and less likely to change,
but will raise increasingly unexpected interactions with the new tech-
nologies. In areas like human error this is alarming, for if we believe
that technology improves − why else would we adopt it? − then, as
human error will still occur, the error must even more surely be due to
the humans involved, not the improved technologies which were
intended to design out error. In other words, the irresistible drive to
adopt improved technology may exacerbate our management of human
error. The economic drivers that push technologies have vested inter-
ests in promoting benefits and belittling problems. And healthcare has
no end of problems: we all want and expect better care, costs are rising
and performance is declining; living longer, and living with chronic ill-
ness, are other problems. Healthcare staff are over-worked and under-
resourced… it is hard to imagine technology changing that. On the
contrary, many technologies (take MRI scanners, heart implants) are
very expensive, and buying into them will exacerbate financial pres-
sures.Safety, security and regulation
In the future there will remain an enduring distinction between safe-
ty and security. In healthcare these mean different things: safety is
about patient and staff safety − basically, following Hippocrates first do
no harm − and security is about controlling access, in particular so that
intruders, rogue patients and staff cannot get inappropriate patient
access, whether that is informational access or physical access.
Security means stopping bad people doing bad things. If a bank loses
money to fraud, this is not unexpected − we all know there are plenty
of bad people around who want to get at our money. It follows that it is
the bank’s responsibility to provide security.
Safety means stopping good people doing bad things. If a nurse is
involved in an untoward incident, this is neither normal nor expected.
It is easy, then, to think the good nurse has gone bad and therefore they
are to blame − this is the conventional bad apple approach to safety.
Indeed, if a good nurse has gone bad, this is a serious betrayal of our
high regard of the nurse, which makes things even worse. The bad
apple theory is very appealing: getting rid of this bad nurse appears to
solve the problem.
In short: security is seen as an organizational responsibility (e.g., the
bank’s or the hospital’s), whereas safety is seen as the individual’s
responsibility (e.g., the nurse’s). Technology improves things that gen-
erate return on investment (security, speed, efficiency, scale and
reach) and safety will not do that while users are scapegoated.
Moreover, safety is hard to assess up-front, unlike simple claims for
low price, speed or efficiency. Unless regulation requires safety to be
assured, we would expect safety to take second place. We therefore
anticipate an increasing debate between safety concerns on the one
hand and regulatory burden on the other. Since currently the regulato-
ry burden for technology is negligible, certainly compared to the rigors
of pharmaceutical development, much could be gained by strengthen-
ing regulation. We suggest careful attention needs to be paid to statu-
tory regulation. To avoid hasty regulation that is ineffective or rapidly
obsolete, we need to think very clearly. Today there is a lively debate
about regulating computer technology; some say (for example) mobile
apps should be more tightly regulated; others say that rigorous proto-
cols (such as randomized controlled trials) take so long the technolo-
gies will be obsolete once there is formal evidence one way or the other.Solving the right problems
Conventional patient records are paper records in folders in cabi-
nets. Many patients have extensive patient records, lab results and so
on, and even more patients have patient records that are in many
places − in hospitals they have visited, consultant’s offices, general
practices, and so on. They are rarely all together where the patient is,
often they get lost or duplicated, and sometimes destroyed by fire or
floods. Many healthcare providers have trucks shipping patient records
around their areas. 
The obvious thing to do is to computerize all the records, and then
use networks to ensure they are always available wherever they are
needed. Looking at records on a screen is simpler than wading through
piles of paper. Since computers already work, all we need to do is set up
a program to scan or type up all the existing paper records. Job done! 
Unfortunately this obvious solution creates new problems.
When a clinician examines a patient, they want to refer to the rele-
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vant parts of the patient’s medical history. If we have simply computer-
ized the patient records, all we have done is made the large, scattered
piles of paper into something that can be viewed on a computer screen,
but now the clinician can only view one window at a time, and they may
easily lose the big picture. Information may be scrolled off the screen,
or be concealed behind pop-ups. In fact, we have merely swapped the
unusability of piles of paper for the unusability of a user interface. 
While we are very familiar with the ways that paper records can fail,
unfortunately we are much less familiar with the ways that computer-
ized records are hard to use and may mislead us.
Tom Landauer’s book The Trouble with Computers makes the
insightful point that computers are enormously successful in areas
where there is commonality that can be computerized — banking,
communications, stock control, office documents, email are all good
examples.6 Areas where they have been less successful are those where
success depends on the human element. My bank account works just
like your bank account, so computerizing either of our accounts is the
same as computerizing everyone’s. But my patient records are different
to yours. The computerization of my records does not help computerize
yours or anyone else’s. Well, that is not quite true. Computerizing my
records helps computerize yours, but when those records are used, we
and the healthcare professionals using them will have different prob-
lems. As the healthcare computer systems scale up to handle more
patients, the usability problems get compounded − in contrast, as bank
accounts are scaled up, things become more uniform and easier to
automate successfully. (Banks also have a very different approach to
problems; a British bank does not have to handle my Russian currency
or it can charge me exorbitant rates, but a hospital that ignored my
X rays would be negligent.)
In healthcare, we have to pay more attention to the broad context of
how information is used. 
This is the concern of User Centered Design (UCD), which Landauer
describes well. The ideas have been taken up in international stan-
dards. In particular, healthcare technologies must be developed using
UCD processes, such as ISO Standard 62366 etc.7 One of the most
important features of the standards is that they make clear that new
technologies are not going to be perfect and need to be tested and
improved to better match how people actually use them. 
UCD is essential in the battle against information overload and the
law of unintended consequences. Technology is introduced to solve a
problem or to improve performance, but this then changes people’s
behaviour and new problems may emerge. 
Originally, email seemed like a wonderful idea − it is cheap, fast,
saves paper, and so on. But we are victims of its very success: now peo-
ple have so many emails that they are overloaded (it is hard to priori-
tize), to say nothing of spam and phishing, flames and people sending
irrelevant or erroneous emails to thousands of recipients. It is now pos-
sible for an ill-conceived email to waste thousands of hours when it is
send to many staff. Emails are a recognized and growing problem; but
the same trend is affecting test results, patient records, drug-drug
interaction reports. For all of these reasonable tasks it seems obvious
they should be computerized, but doing so often results in increasing
amounts of low-level information that can distract people from doing
their real job. 
UCD helps because it emphasizes that no innovation is ever fin-
ished: we have to see how it is used, and continually improve it. Email,
and the rest, have a way to go, and UCD promotes that at each step we
should be user-centred (driven by the needs of users and what they are
trying to do) rather than technology-centred.
Unfortunately, technology creates new users. Computers need tech-
nicians and managers, and these users also contribute to the UCD
improvement cycle. However if we are not very careful, the manage-
ment of the technology gets a life of its own that takes a higher priori-
ty that delivering improved patient care. When investments are made,
the experts are consulted − but now the experts appear to be the tech-
nologists rather than the healthcare professionals or even the patients.
This can cause many problems.
Systems that are under-performing and hence need improving often
induce workarounds by their users. For example, passwords may not
work very well, so nurses find ways to get on with their jobs regardless.
Unfortunately the people the other side of the computers just see the
systems apparently working; they do not see the workarounds or the
unintended risks nurses may be creating as they get things to work.
When the system is improved, the workarounds are not considered suf-
ficiently, and the new system may have unanticipated problems that
even workarounds cannot overcome.The science (rigor) dream (unqualified success) gap
X-rays were discovered by Wilhelm Röntgen in 1895 and immediate-
ly recognized as having huge potential for healthcare. Only a few years
later, one of Thomas Edison’s assistants, Clarence Dally, who had been
enamoured with the potential of X-rays died, of cancer because he had
been experimenting with them every day (Figure 1). 
It is now obvious that X-rays are not risk-free. Every exposure to X-
rays helps a patient yet at the same time exposes them to risk; it is now
routine to make a careful trade-off between the benefits and risks.
Similarly, we now recognize that pharmaceuticals are not magic and
risk-free. In fact, we hardly understand how many pharmaceuticals
work, and it is routine − in fact, a requirement − to perform the gold
standard randomized control trial (RCT) and other forms of careful
experiment before allowing drugs to be released to the market for wider
use. Despite our best endeavours, we have a growing awareness of wor-
rying and complex side-effects, such as growing antibiotic resistance
that has arisen from over-enthusiastic use of antibiotics (not least in
animal husbandry). Some of the original miracle antibiotics are no
longer effective.
Ben Goldacre’s provocative book Bad Pharma documents how phar-
maceutical development sometimes side steps best practice, and pro-
motes drugs that have untoward side effects and other problems.8 For
example in a large RCT, some patients may die for unrelated reasons.
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Figure 1. Clarence Dally X-raying his hand, from the New York
World, August 3, 1903, page 1 (American Newspaper
Repository). 
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The question then is what to do with their data; it is very tempting to
treat them as if they had survived and had been cured. Another exam-
ple success bias in the scientific literature: authors of scientific papers
want to publish their successes rather than their failures. So the liter-
ature under-represents drug trials that fail or uncover unwanted com-
plications. In turn, this means that systematic studies of drug trials
cannot get the correct baseline for experiments, since many experi-
ments are not published. Regulation is starting to address this problem. 
Goldacre makes clear that pharmaceutical development fails scien-
tific standards; yet technology development, such as robotics or com-
puter system development, does not even aspire to the scientific stan-
dards that pharmaceutical research is aware it fails to reach. As
Goldacre puts it, pharmaceutical R&D is close to immoral; yet technol-
ogy R&D is ignorant. This is worrying for the future, as technological
developments may not be adequately tested, tested without satisfactory
controls, and under conditions of vested interests. (Most of the studies
arguing Physician Order Entry systems are either good or bad are writ-
ten by people using the single systems they are publishing about; they
are not good science.) New technologies may have unfortunate side-
effects or other problems (such as forcing risky workarounds) that
nobody has seriously looked for, let alone rigorously assessed.
The last paragraph makes a strong claim, but it is justifiable. Modern
infusion pumps will have been certified for clinical use, and thus evi-
dently passing the applicable safety tests and standards. Yet modern
infusion pumps are driven by computer software (e.g., in their
firmware), which can be modified at will by the manufacturers and
parameterized by hospital technicians. Indeed, software is regularly
updated to fix bugs and to make minor tweaks. Modifying software can
completely change the behaviour of devices. What makes the software
control of devices so appealing is that manufacturers can create a vari-
ety of devices for different market sectors all on top of the same archi-
tecture. Changing the software can change a device from, say, a simple
infusion pump to a dose error reduction intelligent pump. But such
changes can be made after it has been certified for use, without any
further regulatory control. Furthermore, one will struggle in vain to find
any scientific literature on the assessment, let alone RCTs, for such
devices. It does not exist. On the contrary there is a growing literature
on the safety problems of infusion pumps.9
One can hope that the future trends include tightening the culture of
technology development. The standards need improving, and the laisse
faire culture of contemporary development needs addressing. In many
ways, today’s medical technology is at a maturity level comparable to
the unsafe at any speed automobile of the 1960s.10 If we do not address
the lax scientific standards of technology development, it is unlikely
that future technology interventions will improve safety or other desir-
able measures of healthcare performance.
Human factors
The nature of human expertise is that it makes errors likely,11 and
clinicians are highly-skilled experts. To become expert at some process
means automating it, doing some or all of the task without continual
reference to the wider situation. For example, when you learn to drive
a car, you are consciously aware of many factors (such as clutch con-
trol), but as you gain expertise, driving becomes automated and you are
able focus on higher-level goals. As an expert driver, you may find it
seems easy to hold a conversation on a mobile phone, as you now have
the spare cognitive resources to do so. Unfortunately if something
unusual happens, say if a child runs into the road, you may not be pay-
ing enough attention to the situation to take appropriate action − iron-
ically, when you were less of an expert driver, you would have had to pay
very close attention to road conditions, and you may not have been driv-
ing so fast either! The point is that as new technologies will improve
things, we humans will still make errors.
Human factors is already a problem today: complicated gadgets
induce use errors. There is a balance between the time and effort a
manufacturer is going to spend making some technology easy to use
(and safe to use) when the economics of selling the product may not
prioritize those qualities. Usually new technology is procured because
it promises to improve efficiency or reduce costs; safety is an issue cov-
ered by insurance, and is rarely part of the procurement requirements.
Regulation requires some basic safety, but the features that sell devices
often conspire to make the use of the devices more complex. As we dis-
cussed with modes, above, the more features the more complex a
device is to use. Yet typically features sell technology, and the difficul-
ty of use is pushed onto problems for the users. If there is an untoward
incident, it is much easier to blame inadequate training (i.e., the user’s
incompetence) rather than the complexity of the system being used.
Human factors − issues such as situational awareness, tunnel
vision, and so on − is a large and important area. There are two ques-
tions for the future: how can technology help, and how can technology
be improved to be intrinsically safer?How can technology help? 
In time-pressured environments, humans often suffer from tunnel
vision − focusing on the original task and overlooking larger situational
awareness. The classic example is intubating a patient. This is a
demanding, time-critical procedure. The longer it takes, the more pres-
surized the clinician is to complete the procedure. Sometimes the
patient will get into problems, and a tracheotomy is needed − urgently.
Sometimes the clinician is so focused on the intubation that the warn-
ing signs are missed, with disastrous consequences. Here, technology
can help by using monitoring technologies. Remote monitoring of the
patient’s vital signs can enable a trained person out of the pressured
environment to make helpful comments: Hi! I can see you have about ten
seconds before you need to stop… Such ideas lead to concepts like the
electronic ICU (eICU) where a control room monitors perhaps 100 beds.
Experience with such technologies has been positive, especially if care-
ful steps are taken to avoid a them and us division between the clinicians
doing the work and the clinicians monitoring them. Usually a staff rota-
tion is used, so everyone experiences both sides of the camera.How can technology be designed better? 
Manufacturers can use better design processes, such as those out-
lined in standards such as ISO 62366.7 Doing this effectively is hard
work, and with rush to market it is tempting to do the bare minimum,
for all the reasons discussed elsewhere in this article. Here we can
mention three useful ideas:
Discovering use errors takes a long time, and this conflicts with
rapid entry to market. The solution may be to design systems so that
they can be improved in the field. This is actually easy − firmware is
routinely upgraded for bug fixes anyway. What needs doing is logging
device use in sufficient detail so that the manufacturer gets a good
insight into how the device is being used or is failing to be used.
Currently, this information rarely gets back to manufacturers in a use-
ful form.
Many use errors follow predictable patterns. So-called post-comple-
tion errors are common and hard to eliminate just by improving human
procedures. A nurse may use a blood glucometer to measure a patient’s
blood sugar levels. The nurse moves on to the next patient, and then
puts the blood glucometer in a docking station to upload all readings.
As described, at this point the nurse has failed to make a written note
of the levels on the patient’s paper notes, yet because the device has
docked, it has discarded all recordings. This is a post-completion error:
the nurse made the error after they had finished. The solution is to
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redesign the technology, and there are many options here. Why delete
uploaded data, for instance? Why not have a reminder in the device to
confirm the nurse has recorded data before taking another reading?
Why record manually on paper patient notes anyway? This is an exam-
ple of how the standard operating procedures combined with built-in
technological assumptions induce errors (which in this case are unpro-
fessional, and perhaps disciplinary offences), but more thoughtful
design can avoid them.Physicality
The huge leverage computer technology brings, because it is virtual
and can do anything with information (and hence the same piece of
technology can be mass produced for a huge market that has not be pre-
conceived), has a down side. Humans are physical.
The problem can be illustrated very simply. In the old days books
where physical objects, and they looked and felt different. A well-read
book would look worn, and an unread book would look new. You would
recognize bookmarks sticking out of books, you could write annotations
in the margins, you would know how much you have got left to read
before you finish it. You could put a book by the front door of your
house to remind you to pick it up in the morning; you could leave a book
by your bed so it was ready for next time you wanted to read yourself to
sleep. And so on. Now, with electronic readers, all books and documents
look the same − like the general-purpose computer they are on. Of
course, the computer can create colourful covers and images, but the
physical object is always the same: namely, the computer or tablet.
In the old days a patient would go to their doctor and get a paper pre-
scription. They would then go round to the pharmacist and get their
medicines. One problem with this process was that paper prescriptions
were notoriously hard to read, and there was a danger of incorrect dis-
pensing. Today, this process has been computerized. The doctor sends
the prescription electronically to the pharmacy, and the pharmacy can
dispense the drugs almost immediately.
Unfortunately, the patient has lost the physical prescription in this
process. They leave the doctor’s appointment carrying nothing. There is
nothing to remind them to go to the pharmacy to pick up the drugs.
Indeed, pharmacies are now having to dispose of drugs that were effi-
ciently dispensed as soon as they were prescribed but were never col-
lected by the patient.
Just as electronic books are a gift to book publishers − because the
expensive paper book is replaced with a cheap electronic book, free to
reproduce once just one copy has been prepared − increasing use of
computers in healthcare is irresistible. X-ray photographs no longer
need to be developed, put in folders, held up against viewing screens.
They can be emailed. But what they have gained, they have lost in phys-
icality. It may no longer be possible to put an X-ray on a viewer back-to-
front (hence causing a left/right error), but it is very easy to look at the
wrong patient’s X-ray − because they all look the same without their
physicality.
Unfortunately physicality is in direct conflict with the driving eco-
nomics. Pieces of paper are very familiar and we understand exactly
how they work, but computer screens are cost-effective precisely
because they can display lots of information repeatedly without addi-
tion costs. Yet from a safety perspective, the screens all look so similar
they may be confused. 
One solution to this is skeuomorphism: making new technologies
imitate old (and hence more familiar) technologies, otherwise known
as using the right design metaphor. The example here would be to
improve the display so that the paper information being displayed looks
more like actual paper − perhaps with torn edges, discolouring if fre-
quently used, and so on. 
A second solution is affordance: make things look like how they are
intended to be used. For example, a cup with a handle has the affor-
dance that encourages you to pick it up by its handle. Particularly in
emergencies, people need to know what to do intuitively − and affor-
dance is a key part of design.
Thirdly, we can make computers disappear − what is left is a physi-
cal object which happens to do something complicated, but it has been
made invisible to the user. RFID tags and smart chips can be embedded
inside objects so that they can do things and interact with each other,
but the object appears to be normal. A nice example is the hotel key
card; so far as a hotel guest is concerned they behave just like room
keys, but inside some sophisticated cryptography creates a host of ben-
efits − for example, unlike losing a physical key it is not a problem if
you lose a key card, and the locks do not need to be replaced. When
patients routinely have ID tags embedded in them, many of the current
problems of patient barcodes will disappear − no doubt to be replaced
by different problems!
This article is not the place for a deep discussion on design,12 but it
is important to point out that looking up skeuomorphism or affordance
on the internet reveals a huge variety of conflicting opinions. In other
words, these ideas are ways to argue about design, not ways to design.
One still has to do detailed work to make future technologies success-
ful, regardless of their supposed affordances. Despite having nice
words to talk about good design, no future will be an inevitable success.Enhanced and bionic humans
Although we have said that human factors will remain a constant for
the foreseeable future, there is nothing to stop technology enhancing
people. Technology will not be used just to monitor and help make peo-
ple well, but will be used to make them better − better as sportsmen, as
healthcare professionals, or whatever. We already have augmented
reality, where surgeons can see an enhanced view of the insides of
patients. If patients can have brain implants to enhance their lives (to
manage Parkinson, for instance) surgeons will have implants to
improve their skills, using robotics to reduce tremor or computers to
reduce error. After all, the core of the humble calculator − which
reduces drug dose calculation errors − has already shrunk in size from
table-top clockwork of 50 years ago to something so small it could be
swallowed.
Who are the protagonists?
Thinking about the future is science fiction. Key to the success of
any story is to help the reader identify with the key character; or in the
present context of thinking about healthcare futures, are we writing
from a patient’s perspective or from a technologist’s, or a healthcare
professional’s, or … the story makes choices, and if the choices align
with our own interests the story seems more plausible and persuasive.
If the market has developed profitable technologies, it follows that
we (you and me) want those technologies. This truism needs empha-
sizing. Industry stays in business making what we want to buy. Industry
is adept at adapting to make what we find irresistible: this is market
competition. The manufacturers who are better at seducing us survive
and grow. As a consumer, I love iPads (at least I did in 2013), but that
does not mean that iPads can do much good in a professional health-
care environment. Should we fill hospitals with iPads? One part of me,
the private consumer, says yes, they are wonderful! It is interesting
how Blackberries were driven by employers, but iPhones and iPads are
being driven by consumers; increasingly the employee is dictating what
technology the organization they work for uses. But the other part of
me, the clinician, the scientist, the technician, asks for evidence that
they will truly improve healthcare. It doesn’t make such a good story for
me to say I am not sure! If I am in healthcare procurement, I have to
think very carefully to distinguish what I covet as a consumer from
what will actually improve the organization I work for. 
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It is certain that getting evidence, doing experiments (RCTs?) will
delay the market, and there will be huge pressures on us to believe in
the wonderful visions, rather than in the necessity of careful develop-
ment. Healthcare is complex, and just throwing technology at it will not
in itself change anything usefully, other than costing us a lot of money
(which is exactly what the market wants us to do). As we approach the
future, we need to learn how to plan our resources much more careful-
ly and experimentally. The subtle cost-benefits of X-rays were not
apparent immediately, and they rather ruined the original magical
story.
People trying to sell us the future will certainly latch into our acquis-
itive consumer natures − this is who we are as individuals. They are
less likely to latch into us as patients or clinicians, and thus − while
being an engrossing story − they may miss the point and sell us on
technological ideas that do not really improve the world so much as sat-
isfy our consumerist urges. One of the important things science fiction
teaches us is that the future will not be populated only by sensible solu-
tions. While we hope for a happy ending, there will be problems and
even wicked plans, evil empires and natural disasters to overcome
along the way. Who makes the future?
The future of healthcare is about the patient (or stopping people
becoming patients), but patients are not the main stakeholders in
healthcare. Insurance companies, big pharma, doctors, managers, sup-
pliers, builders, governments and many other forces will influence the
future. Will innovation help patients or will it be partly to help monitor
clinicians delivering healthcare? 
It is interesting that since hospitals started introducing computers
that the ratio of managers to clinicians has steadily increased; it is not
totally clear that computers have made delivering healthcare more effi-
cient or safer, but they have certainly increased the volume and
turnover of the business. Moreover, now patient records are computer-
ized, with the obvious benefits, there are also problems. To get prob-
lems fixed, upgrades have to be purchased, and this can be very expen-
sive. Patient records were once on paper; now they are in proprietary
formats, and the manufacturer can lock in the user to their particular
system, so buying upgrades − perpetuating the lock in − seems cheap-
er than moving over to an alternative system.
Conclusions: what we need to do
If we don’t know where we are going, we won’t know when we don’t
get there says the quotable Yogi Berra. The market will surely figure out
a way to make money, and technology will advance in miraculous ways.
Instead, we need to figure out a way to have healthier and happier
patients (and not just treating them as individuals), and to do that
we’ve got to focus on integrating technology with culture rather than
focusing on technology alone. 
In my view the key thing is to think clearly. Initiatives like the UK
Royal College of Physicians Future Hospital Commission, where
thought-leaders − patients and healthcare professionals − have sat
down and worked out what sort of future hospital they need are to be
commended;3 more importantly, they have articulated principles, not
just specific solutions. Such principles are or should be timeless; we
should not plan the future by being technology-driven (e.g., implement-
ing cloud, nanohealth, etc) but by improving along criteria behind prin-
ciples (such as improving patient care or staff support). Articulating
the principles of the futures we want should be a continual process, not
a one-off activity; every day there is a new future to plan, and new dis-
coveries that will change our minds about what is possible and likely.
Future planning should be as much a routine part of healthcare as
responsive care is. If we don’t know what we need, we will get what is
easy and profitable to make; as we emphasized above, what we need
and what we want are often confused.
Are we making the healthcare future we want? If people from the
past suddenly materialized in front of us, we would want to be able to
convince them the world is the better place they had hoped for. What
stories would they take back to help direct their technological trends
and developments?
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